Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma

Experimental and Molecular Pathology

Volumn 95, Issue 1, 2013, Pages 83-90

  Lee, Sung Wei ^a   Chen, Tzu Ju ^a   Lin, Li Ching ^a   Li, Chien Feng ^a,b,c,d   Chen, Li Tzong ^c,e,f,g   Hsing, Chung Hsi ^a   Hsu, Han Ping ^h   Tsai, Chia Jung ⁱ   Huang, Hsuan Ying ^j   Shiue, Yow Ling ⁱ  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

ⁱ NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^j CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

more..

Author keywords

Nasopharyngeal carcinoma; Survival; Thymidylate synthetase; TYMS

Indexed keywords

DIHYDROFOLATE REDUCTASE; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA MINING; DIHYDROFOLATE REDUCTASE GENE; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIMARY TUMOR; THYMIDYLATE SYNTHETASE GENE; TUMOR BIOPSY;

NASOPHARYNGEAL CARCINOMA; SURVIVAL; THYMIDYLATE SYNTHETASE; TYMS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84879588410     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.05.006     Document Type: Article

References (48)

1. Aschele C., et al. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. Journal of Clinical Oncology 1999, 17:1760-1770.
2. Basu A., Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. Journal of Nucleic Acids 2013, (in press). 10.4061/2010/201367.
3. Berg R.W., et al. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase. The Journal of Pharmacology and Experimental Therapeutics 2001, 298:477-484.
4. Cao X.J., et al. Prognostic value of expression of EGFR and nm23 for locoregionally advanced nasopharyngeal carcinoma. Medical Oncology 2011, 29:263-271.
5. Chang E.T., Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2006, 15:1765-1777.
6. Chen M., et al. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas. Oncogene 2007, 26:4817-4824.
7. Chu E., et al. Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex. Molecular and Cellular Biology 1999, 19:1582-1594.
8. Edler D., et al. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clinical Cancer Research 2000, 6:1378-1384.
9. Fan B.J., et al. Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma. Molecular Vision 2008, 14:2484-2491.
10. Flanagan S.A., et al. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization. International Journal of Radiation Oncology, Biology, Physics 2012, 3.
11. Guigay J. Advances in nasopharyngeal carcinoma. Current Opinion in Oncology 2008, 20:264-269.
12. Hardy L.W., et al. Atomic structure of thymidylate synthase: target for rational drug design. Science 1987, 235:448-455.
13. Horie N., et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Structure and Function 1995, 20:191-197.
14. Hu C.M., Chang Z.F. Mitotic control of dTTP pool: a necessity or coincidence?. Journal of Biomedical Science 2007, 14:491-497.
15. Hu C.M., Chang Z.F. Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status. Cancer Research 2008, 68:2831-2840.
16. Hu H.B., et al. Predictive value of thymidylate synthase expression in gastric cancer: a systematic review with meta-analysis. Asian Pacific Journal of Cancer Prevention 2012, 13:261-267.
17. Hui E.P., et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. Journal of Clinical Oncology 2009, 27:242-249.
18. Jensen S.A., et al. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer. Acta Oncologica 2008, 47:1054-1061.
19. Jeyakumar A., et al. Review of nasopharyngeal carcinoma. Ear, Nose, & Throat Journal 2006, 85:168-170. (172-3, 184).
20. Johnston P.G., et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. Journal of Clinical Oncology 1994, 12:2640-2647.
21. Ju J., et al. Regulation of p53 expression by thymidylate synthase. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:3769-3774.
22. Kaneda S., et al. Role in translation of a triple tandemly repeated sequence in the 5'-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Research 1987, 15:1259-1270.
23. Kaneda S., et al. Structural and functional analysis of the human thymidylate synthase gene. The Journal of Biological Chemistry 1990, 265:20277-20284.
24. Kaneda S., et al. Regulatory sequences clustered at the 5' end of the first intron of the human thymidylate synthase gene function in cooperation with the promoter region. Somatic Cell and Molecular Genetics 1992, 18:409-415.
25. Kawakami K., et al. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Research 1999, 19:3249-3252.
26. Kawakami K., et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clinical Cancer Research 2001, 7:4096-4101.
27. Kohalmi S.E., et al. Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate. Journal of Molecular Biology 1991, 220:933-946.
28. Le Q.T., et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 2003, 56:1046-1054.
29. Lee A.W., et al. A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Radiotherapy and Oncology 2011, 98:15-22.
30. Lenz H.J., et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. Journal of Clinical Oncology 1996, 14:176-182.
31. Li Y., et al. Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy. Urology 2007, 69:988-995.
32. Liu J., et al. Thymidylate synthase as a translational regulator of cellular gene expression. Biochimica et Biophysica Acta 2002, 1587:174-182.
33. Liu R.Y., et al. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma. Oncogene 2011, 30:4814-4823.
34. Lo K.W., et al. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5:423-428.
35. Mandola M.V., et al. A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Research 2003, 63:2898-2904.
36. Miyazaki I., et al. A predictive factor for the response to S-1 plus cisplatin in gastric cancer. World Journal of Gastroenterology 2010, 16:4575-4582.
37. Mizutani Y., et al. Significance of thymidylate synthase activity in renal cell carcinoma. Clinical Cancer Research 2003, 9:1453-1460.
38. Nomura T., et al. Clinical significance of thymidylate synthase expression in bladder cancer. International Journal of Urology 2002, 9:368-376.
39. Pestalozzi B.C., et al. Prognostic importance of thymidylate synthase expression in early breast cancer. Journal of Clinical Oncology 1997, 15:1923-1931.
40. Rahman L., et al. Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell 2004, 5:341-351.
41. Razak A.R., et al. Nasopharyngeal carcinoma: the next challenges. European Journal of Cancer 2010, 46:1967-1978.
42. Romain S., et al. DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients. International Journal of Cancer 2001, 95:56-61.
43. Shintani M., et al. Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer. Oncology Reports 2010, 23:1345-1350.
44. Shirasaki T., et al. Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma. BMC Cancer 2008, 8:348.
45. Takemura Y., Jackman A.L. Folate-based thymidylate synthase inhibitors in cancer chemotherapy. Anti-Cancer Drugs 1997, 8:3-16.
46. Weiner K.X., et al. Primary structure of human deoxycytidylate deaminase and overexpression of its functional protein in Escherichia coli. The Journal of Biological Chemistry 1993, 268:12983-12989.
47. Wolden S.L., et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. Journal of Clinical Oncology 2001, 19:1105-1110.
48. Zhang Z., et al. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clinical Cancer Research 2004, 10:7903-7910.